Paying for Patented Drugs is Hard to Justify: An Argument about Time Discounting and Medical Need

Paying for Patented Drugs is Hard to Justify: An Argument about Time Discounting and Medical Need

Source :

• Journal of Applied Philosophy [ 0264-3758 ] ; 2012-08.

Descripteurs français

• Wicri :
  • topic : Antibiotique, Taux d'escompte, Escompte, Médicament générique, Politique publique.

English descriptors

• KwdEn :
  • Additional weighting, Antibiotic, Atemporal approach, Atemporal list, Chemical entities, Commodity, Competition commission, Cost savings, Current budgets, Current healthcare budgets, Current system, Different people, Different times, Discount rate, Discounting, Drug, Drug cocktail, Drug development, Drug discovery, Equal claim, Essential medicines, Fund drug development, Future reductio, Generic, Generic drug, Generic drugs, Generic version, Generics account, Generics manufacturers, Global health, Greater number, Healthcare, Healthcare budget, Healthcare system, Healthcare systems, Higher priority, Highest priority person, Incentivising drug development, Innovation premium, James wilson, John broome, John taurek, Larger group, Larger number, Latest medicines, Limited resource, Mark sheehan, Medical ethics, Medical need, Medical treatment, Medical treatments, Moral claim, Moral claims, Moral duty, Moral urgency, More people, Narrow intervals, Need treatment, Numbers scepticism, Obvious solution, Overall drugs budget, Patent claim, Patent period, Patent system, Pharmaceutical, Pharmaceutical companies, Pharmaceutical innovation, Prima facie obligation, Proportionate contribution, Psychological propensity, Public affairs, Public domain, Public goods, Public healthcare systems, Public policy, Pure discount rate, Pure discounting, Resource, Resource constraints, Same unit, Scarce resource, Scarce resources, Schematic principle, Sector inquiry, Something worryingly, Strong reason, Such cases, Such schemes, Support drug innovation, Time discounting, Uncontroversial assumption, Whilst.
• Teeft :
  • Additional weighting, Antibiotic, Atemporal approach, Atemporal list, Chemical entities, Commodity, Competition commission, Cost savings, Current budgets, Current healthcare budgets, Current system, Different people, Different times, Discount rate, Discounting, Drug, Drug cocktail, Drug development, Drug discovery, Equal claim, Essential medicines, Fund drug development, Future reductio, Generic, Generic drug, Generic drugs, Generic version, Generics account, Generics manufacturers, Global health, Greater number, Healthcare, Healthcare budget, Healthcare system, Healthcare systems, Higher priority, Highest priority person, Incentivising drug development, Innovation premium, James wilson, John broome, John taurek, Larger group, Larger number, Latest medicines, Limited resource, Mark sheehan, Medical ethics, Medical need, Medical treatment, Medical treatments, Moral claim, Moral claims, Moral duty, Moral urgency, More people, Narrow intervals, Need treatment, Numbers scepticism, Obvious solution, Overall drugs budget, Patent claim, Patent period, Patent system, Pharmaceutical, Pharmaceutical companies, Pharmaceutical innovation, Prima facie obligation, Proportionate contribution, Psychological propensity, Public affairs, Public domain, Public goods, Public healthcare systems, Public policy, Pure discount rate, Pure discounting, Resource, Resource constraints, Same unit, Scarce resource, Scarce resources, Schematic principle, Sector inquiry, Something worryingly, Strong reason, Such cases, Such schemes, Support drug innovation, Time discounting, Uncontroversial assumption, Whilst.

Abstract

• https://api.istex.fr/document/ADE428E04F17690D175183E6EC7162DEC29E46FF/fulltext/pdf

Affiliations:

• Royaume-Uni
• Angleterre, Grand Londres
• Londres
• University College de Londres

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 005674
• to stream Istex, to step Curation: 005674
• to stream Istex, to step Checkpoint: 000D50
• to stream Main, to step Merge: 003897
• to stream Main, to step Curation: 003880

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003880 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003880 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:ADE428E04F17690D175183E6EC7162DEC29E46FF
   |texte=   Paying for Patented Drugs is Hard to Justify: An Argument about Time Discounting and Medical Need
}}

This area was generated with Dilib version V0.6.32. Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022